FibrinSealants Market -By Technology 2021 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Fibrin Sealants Market
Fibrin Sealants Market -By Technology (Viral Inactivation, Autologous Donation, Recombinant Production and Others); By Application (Cardiovascular Surgery, Thoracic Surgery, Neurosurgery, Plastic and Reconstructive Surgery, Dental Surgery and Others); & Geography – Forecast (2016-2021)
Report Code : HCR 0095
Published: 17 February, 2016   No. of pages: 142

  • Report Description
  • Table of Contents
  • Customization Options
Fibrin sealant is also known as fibrin glue. It is a biological agent which controls bleeding in those injuries or surgeries in which cautery, ligation, or suturing do not provide adequate hemostasis. It is a mixture of fibrinogen and thrombin which is applied on the affected area to restrain hemorrhage. Moreover, it is also used as delivery device to deliver long-term regional growth factor or other drug delivery. Additionally, fibrin sealant is a brilliant blood clotting agent and it can seal tissues in order to prevent lymphatic leak or serous fluid accumulation. Owing to these mentioned properties, fibrin sealant is the most ideally suited component for lessening the occurrence of fluid accumulation, hematomas, ecchymoses, swelling and more. It also perhaps eradicate the need for drains following rhytidectomy.

Presently, fibrin sealant is an emerging industry. However, there are only limited manufacturers who are actually involved in the technological research of fibrin selants that are capable of clinical feasibility. The major factor that is all set to drive the fibrin sealant market is the increase in the number of ambulatory surgical centers. These centers are low-priced as well as easily available to patients. Also, ambulatory surgeries do not necessitate overnight hospital stays. The growing fame of ambulatory surgical centers has augmented the amount of patients, which consequently aggregate the number of surgeries being performed. Furthermore, owing to the increase in surgeries, the demand for wound closure products which include fibrin sealants has also experienced an upsurge. Huge pool of patients drives the market in evolving countries.

The global market for fibrin sealants was estimated to be $XX billion in 2015. The global market for fibrin sealants is estimated to grow at a CAGR of XX% and is forecast to reach $XX billion by 2021. The fibrin sealants are forecast to have the highest growth of XX% during the forecast period 2016-2021. Americas and APAC together are estimated to occupy a share of more than XX% in 2015.

The application segment is the major driver for the fibrin sealants market to grow. Fibrin sealants find their applications in various segments like cardiovascular surgery, thoracic surgery, neurosurgery, orthopedic Surgery, plastic and reconstructive surgery and more. North America dominated the global fibrin sealants market. The medical development in this region is all set to drive the demand of fibrin sealant materials. Major players involved in this market are mainly concentrating on R&D initiatives and new product developments to cater the needs of customers. Moreover, booming medical industry will directly impact the demand of the fibrin sealants over the foreseeable period.

Fibrin Sealants Market

Americas dominates the fibrin glue or sealant market owing to large aging population and growth in number of surgical procedures. Additionally, China and India are the fastest growing fibrin sealants market in APAC region followed by Europe and RoW. Fibrin sealants market to have highest growth in the next few years due to advance in technology and increasing aging population. Americas accounts to XX% of the global market for fibrin sealants in 2015 and is the fastest growing market followed by APAC. 

The global fibrin sealants market is evaluated based on key attributes such as technology, application and others. Each of the segmentations in the report has been studied to give comprehensive analysis of global fibrin sealants market. The overall market has also been consolidated from the perspective of different geographic locations into standard geographic regions and key economies for this market. Additionally, this report encompasses opportunity analysis, porter analysis, pricing analysis and market forces such as drivers, constraints and challenges that are involved to drive the overall market.

The key players profiled in this report are:
  • Quantum OPS
  • Bayer AG and others

This report gives detailed information about the product value chain right from the beginning which includes raw materials till end-use. The market is analyzed based on the key attributes such as the power in the hands of producers and consumers, analysis on the degree of competition, and threats from substitutes and new entrants. The study includes the demand of this particular market on a global and regional scale for a six year period of 2016-2021, both in terms of volume(kilo tons) and revenue($ million).
1. Market Overview
2. Executive Summary
3. Fibrin Sealants Landscape

   3.1. Market Share Analysis
   3.2. Comparative Analysis
      3.2.1. Product Benchmarking
      3.2.2. End user Profiling
      3.2.3. Top 5 Financials Analysis
4. Fibrin Sealants Forces
   4.1. Market Drivers
   4.2. Market Constraints & Challenges
   4.3. Attractiveness of the Fibrin Sealants
      4.3.1. Power of Suppliers
      4.3.2. Threats From New Entrants
      4.3.3. Power of Buyer
      4.3.4. Threat From Substitute Product
      4.3.5. Degree of Competition
5. Fibrin Sealants-Strategic Analysis
   5.1. Fibrin Sealants - Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunity Analysis
   5.4. Product Life Cycle
   5.5. Suppliers and Distributors
   5.6. SWOT Analysis
6. Fibrin Sealants - By Technology
   6.1. Viral Inactivation
   6.2. Autologous Donation
   6.3. Recombinant Production
   6.4. Others
7. Fibrin Sealants-By Application
   7.1. Cardiovascular Surgery
   7.2. Thoracic Surgery
   7.3. Neurosurgery
   7.4. Orthopaedic Surgery
   7.5. Plastic And Reconstructive Surgery
   7.6. Dental Surgery
   7.7. Others
8. Fibrin Sealants -By Geography
   8.1. Americas
      8.1.1. U.S.
      8.1.2. Canada
      8.1.3. Mexico
      8.1.4. Brazil
      8.1.5. Others
   8.2. Europe
      8.2.1. U.K.
      8.2.2. Germany
      8.2.3. Italy
      8.2.4. France
      8.2.5. Others
   8.3. Asia
      8.3.1. China
      8.3.2. South Korea
      8.3.3. Japan
      8.3.4. India
      8.3.5. Others
   8.4. Rest of The World (RoW)
9. Fibrin Sealants Entropy
   9.1. New Product Developments
   9.2. Mergers and Acquisitions
10. Company Profiles
   10.1. Ethicon US, LLC
   10.2. Drugs.com
   10.3. The Medicines Company
   10.4. Baxter International Inc
   10.5. Biegler GmbH
   10.6. LifeBond LTD
   10.7. Tissuemed Ltd.
   10.8. Integra LifeSciences Corporation
   10.9. Cohera Medical, Inc
   10.10. Surgical Specialties Corporation
   10.11. OCULAR THERAPEUTIX, INC.
   10.12. AccessClosure, Inc.
   10.13. Cryolife, Inc.
   10.14. Haemacure Corporation
   10.15. HyperBranch Medical Technology
   10.16. Neomend, Inc.
   10.17. Omrix Biopharmaceuticals Inc.
   10.18. Vascular Solutions, Inc.
   10.19. Vivostat A/S
   10.20. Z-Medica Corporation
   10.21. Zymogenetics, Inc.
   10.22. SurgRx, Inc.
   10.23. GTC Biotherapeutics
   10.24. Possis Medical
 *More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"

Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports